nach oben

International Journal of Diabetes in Developing Countries

Erschienen in:

12.08.2022 | Correction

Correction to: Personalized glycemic response led digital therapeutics program improves time in range in a period of 14 days

verfasst von: Ritika Verma, Shefali Bhardwaj, Tejal Lathia, Sanjay Kalra, Ruchira Ranadive, Snehal Tanna, Mahesh Padsalge, Archana Juneja, Kirti Samudra, Piya Ballani Thakkar, Vandana Jain, Vishal Kini, Sneha Kothari, Saimala Guntur, Shilpa Joshi, Arbinder Singal

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Excerpt

Correction to: International Journal of Diabetes in Developing Countries …

Titel: Correction to: Personalized glycemic response led digital therapeutics program improves time in range in a period of 14 days
verfasst von: Ritika Verma
Shefali Bhardwaj
Tejal Lathia
Sanjay Kalra
Ruchira Ranadive
Snehal Tanna
Mahesh Padsalge
Archana Juneja
Kirti Samudra
Piya Ballani Thakkar
Vandana Jain
Vishal Kini
Sneha Kothari
Saimala Guntur
Shilpa Joshi
Arbinder Singal
Publikationsdatum: 12.08.2022
Verlag: Springer India
Erschienen in: International Journal of Diabetes in Developing Countries / Ausgabe 3/2023
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-022-01127-7

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2023

Improvement of biochemical and hematological parameters in alloxan-induced diabetic rats via administration of ethanol extract of Garcinia kola seeds

Nerve conduction study abnormalities in Indian children with type 1 diabetes

Serum glucose, a cost-effective alternate of plasma glucose in diagnosing and monitoring diabetes mellitus

Pattern of clinical/bacteriological profile and follow-up of symptomatic urinary tract infection in patients with diabetes: a cross-sectional study from North India

Effects of dapagliflozin combined with short-term intensive insulin therapy on β-cell function in patients with newly diagnosed type 2 diabetes mellitus—a randomized controlled study

Evaluation of progression in metabolic parameters along with markers of subclinical inflammation and atherosclerosis among normoglycemic first degree relatives of type 2 diabetes mellitus patients